Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
銘柄名/コード:
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/04/2423 : 34PR Newswire (US)TWN Communications Appoints Jonathan Adelstein as Executive Vice President, Chief Strategy and External Affairs Officer
2024/04/2423 : 33Business WireLocatorX Names Jody Spencer as New Chief Marketing Officer
2024/04/2423 : 32GlobeNewswire Inc.Xtract One Closes $7.2M Public Offering and $1.4M Investment by Strategic PartnerTSX:XTRAXtract One Technologies Inc
2024/04/2423 : 32GlobeNewswire Inc.Xtract One Closes $7.2M Public Offering and $1.4M Investment by Strategic PartnerTG:0PLXtract One Technologies Inc
2024/04/2423 : 31GlobeNewswire Inc.Class 1 Nickel Updates Resource Estimate on High-Grade Alexo South Nickel Sulphide Deposit – Significant Increases in Indicated and Inferred Resources Over the 2020 Estimate77C
2024/04/2423 : 31PR Newswire (Canada)Silver Mountain Announces Closing of Prospectus OfferingTSXV:AGMRSilver Mountain Resources Inc
2024/04/2423 : 31PR Newswire (US)GenScript Biotech Releases 2023 ESG Report: Deepening Green Development Practices, Constructing Sustainable Future Blueprint
2024/04/2423 : 30GlobeNewswire Inc.BioXcel Therapeutics Announces Late-Breaking Abstract on Preliminary Findings from Phase 2 Investigator-Sponsored Trial of BXCL701 and KEYTRUDA® in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Selected for Presentation at 2024 ASCO Annual MeetingNASDAQ:BTAIBioXcel Therapeutics Inc
2024/04/2423 : 30PR Newswire (US)Tquila announces launch and first close of $60 million Tquila Paloma Fund, marking milestone in tech venture investment
2024/04/2423 : 30PR Newswire (US)Vaccines Market Worth $94.9 billion | MarketsandMarkets™
2024/04/2423 : 30PR Newswire (US)Tquila announces launch and first close of $60 million Tquila Paloma Fund, marking milestone in tech venture investment
2024/04/2423 : 30PR Newswire (US)Livability.com Unveils Annual List of America's Best Small to Mid-Sized Cities
2024/04/2423 : 30PR Newswire (US)Vaccines Market Worth $94.9 billion | MarketsandMarkets™
2024/04/2423 : 30PR Newswire (US)TIME Magazine ranks Kuali in Top 100 of the World's Top EdTech Companies of 2024
2024/04/2423 : 30PR Newswire (US)VIRTUAL DINING CONCEPTS® EXPANDS ITS RELATIONSHIP WITH IHOP®NYSE:DINDine Brands Global Inc
2024/04/2423 : 29GlobeNewswire Inc.Pixalate Releases Top 100 Connected TV (CTV) Bundle ID Rankings For Global Open Programmatic Advertising on Roku, Amazon Fire TV, Samsung Smart TV, and Apple TV in March 2024
2024/04/2423 : 29Business WireKBRA Releases Research – Structured Credit Trend Watch: CLO Issuance in Bloom—First Quarter Record for Middle Market
2024/04/2423 : 29PR Newswire (US)A New Era of Growth: 2024 GAC International Global Distributor Conference
2024/04/2423 : 28Business WireDas fehlende Stück – TUC s.r.l. präsentiert TUC.tiny: den Schlüssel zur Neuen Mobilität
2024/04/2423 : 27Business WireMiami Beach Foundation Appoints Three Cultural Luminaries to Board
2024/04/2423 : 26Business WireAccessia Health Appoints Tiara Green to President
2024/04/2423 : 26PR Newswire (Canada)L'Expédition Leucan : près de 230 000 $ amassés en soutien aux enfants atteints de cancer
2024/04/2423 : 24PR Newswire (US)Hankook Tire Bolsters Sales Organization with New Appointments
2024/04/2423 : 23Business WireAulos Bioscience to Present Updated Phase 1/2 Clinical Trial Results for Novel IL-2 Therapeutic AU-007 in Advanced Solid Tumor Cancers at 2024 ASCO Annual Meeting
2024/04/2423 : 23PR Newswire (Canada)D2L Releases 2024 Sustainability ReportTSX:DTOLD2L Inc
2024/04/2423 : 23PR Newswire (US)D2L Releases 2024 Sustainability ReportTSX:DTOLD2L Inc
2024/04/2423 : 22Business WireSheppard Mullin Lands Healthcare Partner Stephanie Marcantonio in New York
2024/04/2423 : 21Crypto BriefingStrike launches in Europe to offer Bitcoin servicesCOIN:BTCUSDBitcoin
2024/04/2423 : 20Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
2024/04/2423 : 20PR Newswire (US)Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc

最近閲覧した銘柄

Delayed Upgrade Clock